IT8920170A0 - Derivati fluorurati di acidi biliari, loro preparazione e composizioni farmaceutiche che li contengono. - Google Patents

Derivati fluorurati di acidi biliari, loro preparazione e composizioni farmaceutiche che li contengono.

Info

Publication number
IT8920170A0
IT8920170A0 IT8920170A IT2017089A IT8920170A0 IT 8920170 A0 IT8920170 A0 IT 8920170A0 IT 8920170 A IT8920170 A IT 8920170A IT 2017089 A IT2017089 A IT 2017089A IT 8920170 A0 IT8920170 A0 IT 8920170A0
Authority
IT
Italy
Prior art keywords
contain
preparation
pharmaceutical compositions
bile acids
fluorinated derivatives
Prior art date
Application number
IT8920170A
Other languages
English (en)
Other versions
IT1229570B (it
Inventor
Roberto Pellicciari
Aldo Roda
Giuliano Frigerio
Original Assignee
Giuliani Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Giuliani Spa filed Critical Giuliani Spa
Publication of IT8920170A0 publication Critical patent/IT8920170A0/it
Priority to IT8920170A priority Critical patent/IT1229570B/it
Priority to US07/506,837 priority patent/US5061701A/en
Priority to DK90106971.6T priority patent/DK0393493T3/da
Priority to ES90106971T priority patent/ES2080764T3/es
Priority to AT90106971T priority patent/ATE131173T1/de
Priority to EP90106971A priority patent/EP0393493B1/en
Priority to DE69023947T priority patent/DE69023947T2/de
Priority to JP02096161A priority patent/JP3122448B2/ja
Priority to CA002014545A priority patent/CA2014545C/en
Application granted granted Critical
Publication of IT1229570B publication Critical patent/IT1229570B/it
Priority to US07/761,440 priority patent/US5175320A/en
Priority to GR950403523T priority patent/GR3018387T3/el

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J9/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane
    • C07J9/005—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane containing a carboxylic function directly attached or attached by a chain containing only carbon atoms to the cyclopenta[a]hydrophenanthrene skeleton
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J51/00—Normal steroids with unmodified cyclopenta(a)hydrophenanthrene skeleton not provided for in groups C07J1/00 - C07J43/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Nutrition Science (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IT8920170A 1989-04-17 1989-04-17 Derivati fluorurati di acidi biliari, loro preparazione e composizioni farmaceutiche che li contengono. IT1229570B (it)

Priority Applications (11)

Application Number Priority Date Filing Date Title
IT8920170A IT1229570B (it) 1989-04-17 1989-04-17 Derivati fluorurati di acidi biliari, loro preparazione e composizioni farmaceutiche che li contengono.
US07/506,837 US5061701A (en) 1989-04-17 1990-04-09 Fluorinated bile acid derivatives, processes for the preparation thereof and pharmaceutical compositions containing them
AT90106971T ATE131173T1 (de) 1989-04-17 1990-04-11 Fluorierte gallensäure-derivate, verfahren zu deren herstellung und pharmazeutische zusammensetzungen daraus.
ES90106971T ES2080764T3 (es) 1989-04-17 1990-04-11 Derivados de acidos biliares fluorados, procedimientos para su preparacion y composiciones farmaceuticas que los contienen.
DK90106971.6T DK0393493T3 (da) 1989-04-17 1990-04-11 Fluorerede galdesyrederivater, fremgangsmåder til fremstilling heraf og farmaceutiske midler, som indeholder dem
EP90106971A EP0393493B1 (en) 1989-04-17 1990-04-11 Fluorinated bile acid derivatives, processes for the preparation thereof and pharmaceutical compositions containing them
DE69023947T DE69023947T2 (de) 1989-04-17 1990-04-11 Fluorierte Gallensäure-Derivate, Verfahren zu deren Herstellung und pharmazeutische Zusammensetzungen daraus.
JP02096161A JP3122448B2 (ja) 1989-04-17 1990-04-11 ふっ素化胆汁酸誘導体、その製造方法ならびにそれらを含有する製薬組成物
CA002014545A CA2014545C (en) 1989-04-17 1990-04-12 Fluorinated bile acid derivatives, processes for the preparation thereof and pharmaceutical compositions containing them
US07/761,440 US5175320A (en) 1989-04-17 1991-09-18 Fluorinated bile acid derivatives, processes for the preparation thereof and pharmaceutical compositions containing them
GR950403523T GR3018387T3 (en) 1989-04-17 1995-12-13 Fluorinated bile acid derivatives, processes for the preparation thereof and pharmaceutical compositions containing them.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT8920170A IT1229570B (it) 1989-04-17 1989-04-17 Derivati fluorurati di acidi biliari, loro preparazione e composizioni farmaceutiche che li contengono.

Publications (2)

Publication Number Publication Date
IT8920170A0 true IT8920170A0 (it) 1989-04-17
IT1229570B IT1229570B (it) 1991-09-04

Family

ID=11164384

Family Applications (1)

Application Number Title Priority Date Filing Date
IT8920170A IT1229570B (it) 1989-04-17 1989-04-17 Derivati fluorurati di acidi biliari, loro preparazione e composizioni farmaceutiche che li contengono.

Country Status (10)

Country Link
US (1) US5061701A (it)
EP (1) EP0393493B1 (it)
JP (1) JP3122448B2 (it)
AT (1) ATE131173T1 (it)
CA (1) CA2014545C (it)
DE (1) DE69023947T2 (it)
DK (1) DK0393493T3 (it)
ES (1) ES2080764T3 (it)
GR (1) GR3018387T3 (it)
IT (1) IT1229570B (it)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5175320A (en) * 1989-04-17 1992-12-29 Giuliani S.P.A. Fluorinated bile acid derivatives, processes for the preparation thereof and pharmaceutical compositions containing them
ATE169930T1 (de) * 1993-03-10 1998-09-15 Magainin Pharma Steroidderivate, pharmazeutische zusammensetzungen die sie enthalten und ihre verwendung als antibiotika oder desinfektionsmittel
US5856535A (en) * 1994-08-18 1999-01-05 Magainin Pharmaceuticals, Inc. Aminosterol ester compounds
US5840740A (en) * 1995-06-07 1998-11-24 Magainin Pharmaceuticals Inc. Aminosterol compounds and a method of treating infection using the aminosterol compounds
US5840936A (en) * 1995-06-07 1998-11-24 Magainin Pharmaceuticals Inc. Aminosterol compounds useful as inhibitors of the sodium/proton exchanger (NHE)
US5792635A (en) * 1995-06-07 1998-08-11 Magainin Pharmaceuticals, Inc. Method of inhibiting the sodium/proton exchanger NHE3 and method of inhibiting growth by administering squalamine
US6143738A (en) * 1995-06-07 2000-11-07 Magainin Pharmaceuticals, Inc. Therapeutic uses for an aminosterol compound
US5763430A (en) * 1995-06-07 1998-06-09 Magainin Pharmaceuticals Inc. Method of treating a viral infection by administering a steroid compound
US5874597A (en) * 1995-06-07 1999-02-23 Magainin Pharmaceuticals, Inc. Certain aminosterol compounds and pharmaceutical compositions including these compounds
US5994336A (en) * 1995-06-07 1999-11-30 Magainin Pharmaceuticals Inc. Method of inhibiting proliferation of cells by administering an aminosterol compound
US5847172A (en) * 1995-06-07 1998-12-08 Magainin Pharmaceuticals Inc. Certain aminosterol compounds and pharmaceutical compositions including these compounds
US5795885A (en) * 1995-06-07 1998-08-18 Magainin Pharmaceuticals Inc. Method of inhibiting profileration of cells by administering an aminosterol compound
US6596712B2 (en) 1996-04-26 2003-07-22 Genaera Corporation Treatment of carcinomas using squalamine in combination with other anti-cancer agents or modalities
DK0910382T3 (da) * 1996-04-26 2003-10-06 Genaera Corp Squalamin i kombination med andre anticancermidler til behandling af tumorer
US6262283B1 (en) 1996-12-06 2001-07-17 Magainin Pharmaceuticals Inc. Stereoselective synthesis of 24-hydroxylated compounds useful for the preparation of aminosterols, vitamin D analogs, and other compounds
EP1274718B1 (en) * 2000-04-12 2006-10-18 Genaera Corporation A process for the preparation of 7.alpha.-hydroxy 3-aminosubstituted sterols using intermediates with an unprotected 7.alpha.-hydroxy group
EP1392714B1 (en) 2001-03-12 2005-08-31 Intercept Pharmaceuticals, Inc. Steroids as agonists for fxr
ITMI20021532A1 (it) * 2002-07-12 2004-01-12 Roberto Pellicciari Composti chimici
US10987362B2 (en) 2004-03-12 2021-04-27 Intercept Pharmaceuticals, Inc. Treatment of fibrosis using FXR ligands
ES2533993T3 (es) 2004-03-12 2015-04-16 Intercept Pharmaceuticals, Inc. Tratamiento de fibrosis usando ligandos de FXR
ITMI20050912A1 (it) * 2005-05-19 2006-11-20 Erregierre Spa Processo di preparazione di acidi 3-a-ya(b)-diidrossi-6-a(b)-alchil-5b-colanici
CN101679476B (zh) 2007-01-19 2014-05-07 英特塞普特医药品公司 23取代的胆汁酸作为tgr5调节剂及其使用方法
EP2324046B1 (en) 2008-07-30 2014-09-03 Intercept Pharmaceuticals, Inc. Tgr5 modulators and methods of use thereof
CN104370990A (zh) * 2008-11-19 2015-02-25 英特塞普特医药品公司 G蛋白偶联受体5(tgr5)调节剂及其使用方法
US9982008B2 (en) 2012-06-19 2018-05-29 Intercept Pharmaceuticals, Inc. Preparation and uses of obeticholic acid
NZ734451A (en) 2012-06-19 2018-12-21 Intercept Pharmaceuticals Inc Preparation, uses and solid forms of obeticholic acid
CN110437297B9 (zh) 2013-08-01 2022-01-11 美国卫生和人力服务部 法尼醇x受体的抑制剂和在医学中的用途

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4460509A (en) * 1981-08-19 1984-07-17 Beth Israel Medical Center Chemical synthesis
US4545938A (en) * 1983-11-02 1985-10-08 Beth Israel Medical Center Chemical synthesis
US4648995A (en) * 1983-11-02 1987-03-10 Beth Israel Medical Center Chemical synthesis

Also Published As

Publication number Publication date
EP0393493A3 (en) 1992-05-27
US5061701A (en) 1991-10-29
DE69023947T2 (de) 1996-05-30
DK0393493T3 (da) 1996-04-15
GR3018387T3 (en) 1996-03-31
JPH02292300A (ja) 1990-12-03
IT1229570B (it) 1991-09-04
ATE131173T1 (de) 1995-12-15
EP0393493A2 (en) 1990-10-24
DE69023947D1 (de) 1996-01-18
JP3122448B2 (ja) 2001-01-09
CA2014545C (en) 2001-08-14
EP0393493B1 (en) 1995-12-06
CA2014545A1 (en) 1990-10-17
ES2080764T3 (es) 1996-02-16

Similar Documents

Publication Publication Date Title
IT8920170A0 (it) Derivati fluorurati di acidi biliari, loro preparazione e composizioni farmaceutiche che li contengono.
IT8722343A0 (it) Derivati di acidi biliari loro preparazione e composizioni farmaceutiche che li contengono.
IT8920169A0 (it) Derivati di acidi biliari, loro preparazione e composizioni farmaceutiche che li contengono.
IT1206112B (it) Nuovi derivati di acidi biliari, procedimento per la loro preparazione e relative composizioni farmaceutiche.
IT8322572A0 (it) Derivati di acidi biliari, procedimento per la loro preparazione e relative composizioni farmaceutiche.
IT8424187A0 (it) Derivati di acidi biliari, procedimento per la loro preparazione e relative composizioni farmaceutiche.
IT7827493A0 (it) Derivati di acidi amidinosolfonici, processo per la loro preparazione e composizioni farmaceutiche che contengono questi derivati.
IT1227456B (it) Nuovi alcossi derivati di ginkgolidi, loro preparazione e composizioni terapeutiche che li contengono
IT8667976A0 (it) Derivati teofillinmetilditiolanici e teofillinmetilditianici procedimento per la loro preparazione e composizioni farmaceutiche che li comprendono
IT9021305A0 (it) Derivati aminopropanolici, procedimenti per la loro preparazione e composizioni farmaceutiche che li contengono
IT8921513A0 (it) Derivati dell'acido piroglutammico, loro preparazioni e composizioni farmacuetiche che li contengono.
IT8922275A0 (it) Nuovi derivati di corticosteroidi, procedimento per la loro preparazione e composizioni farmaceutiche che li contengono.
IT8224755A0 (it) Nuovi derivati di acidi fenilacetici, loro preparazione e composizioni che li contengono.
IT9019494A0 (it) Derivati insaturi di acidi biliari, loro preparazione e composizione farmaceutiche che li contengono
IT8224576A0 (it) Derivati di acidi aminopiridincarbossilici,loro metodi di sintesi e composizioni farmaceutiche che licontengono
IT1219567B (it) Derivati di forskolina,loro procedimento ed intermedi di preparazione,loro applicazione in qualita' di medicamenti e composizioni farmaceutiche che li contengono
IT8920996A0 (it) Derivati di 2 ammino 1,2,3,4 tetraidronaftalene ad attivita' cardiovascolare, procedimento per la loro preparazione e composizioni farmaceutiche che li contengono.
IT8020764A0 (it) Esteri e derivati chinucleidinici di acidi fenossicarbossilici, procedimento per la loro preparazione e relative composizioni farmaceutiche.
IT8321909A0 (it) Derivati di acidi biliari, procedimento per la loro preparazione e relative composizioni farmaceutiche.
IT1216120B (it) Derivati n_cicloalchilaminoetilbenzamidici, loro preparazione e composizioni farmaceutiche che li contengono.
IT8323912A0 (it) Derivati di acidi bifenililalcanoici, loro preparazione e composizioni farmaceutiche che licontengono.
ITFI920134A1 (it) Derivati 7-neopentil xantinici, loro preparazione e composizioni farmaceutiche che li contengono
IT8222632A0 (it) Derivati di acidi biliari,procedimento per la loro preparazione e relative composizioni farmaceutiche
IT8920387A0 (it) Derivati n dialchilaminoetilbenzamidici fluorurati, loro preparazione e composizioni farmaceutiche che li contengono.
ITMI930420A0 (it) Nuovi derivati di acidi biliari procedimento per la loro preparazione composizioni farmaceutiche che li contengono

Legal Events

Date Code Title Description
TA Fee payment date (situation as of event date), data collected since 19931001

Effective date: 19960424